About this trial
To learn if an accelerated recovery program can shorten the length of hospital stay in patients having minimally invasive liver surgery.
Eligibility criteria
Qualifiers
Tumor amenable to MIS Kawaguchi-Gayet grade I hepatectomy (see figure 1 below)
No evidence of cirrhosis (based on imaging, evidence of portal hypertension, clinical features, or laboratory results)
No significant cardiopulmonary disease that would prevent patients from undergoing MIS resection
Ability to stay within 50 miles of medical center for immediate postop period
Disqualifiers
Tumors NOT amenable to MIS Kawaguchi-Gayet grade I hepatectomy
Tumors not amenable to MIS or Robotic-assisted surgical resection
Evidence of Cirrhosis on imaging, clinically, or lab testing
Inability to stay within 50 miles of the Cancer Center in the immediate post-operative period
Trial design
Treatments tested in this trial
- Questionnaires
Treatment groups
Sponsors and collaborators
M.D. Anderson Cancer Center
Lead sponsor
Intuitive Surgical
Collaborator